Hormonal manipulations in the luteal phase to coordinate subsequent antral follicle growth during ovarian stimulation

被引:28
作者
Fanchin, R [1 ]
机构
[1] Hop Antoine Beclere, Dept Obstet & Gynecol & Reprod Med, F-92141 Clamart, France
关键词
early antral follicles; follicular synchronization; FSH; GnRH antagonist; oestradiol; ovarian stimulation;
D O I
10.1016/S1472-6483(10)61115-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
During the early follicular phase in the menstrual cycle, antral follicle sizes are often markedly heterogeneous. These follicular size discrepancies may, at least in part, result from the early exposure of FSH-sensitive follicles to gradient FSH concentrations during the preceding luteal phase. In addition, they potentially affect the results of ovarian stimulation. Indeed, pre-existing follicle size discrepancies may encumber coordinated follicular growth during ovarian stimulation, thereby reducing the number of follicles that reach maturation at once. To investigate this issue, three clinical studies were conducted to test the hypothesis that luteal FSH suppression could coordinate follicular growth. First, luteal FSH concentrations were artificially lowered by administering physiological oestradioll doses and measured follicular characteristics on the subsequent day 3. Second, it was verified whether luteal oestradiol administration could promote the coordination of follicular growth during ovarian stimulation and improve its results. Third, the effects of premenstrual gonadotrophin-releasing hormone (GnRH) antagonist administration on follicular characteristics were assessed during the early follicular phase. The results showed that luteal FSH suppression by either oestradiol or GnRH antagonist administration reduces the size and improves the homogeneity of early antral follicles during the early follicular phase, an effect that persists during ovarian stimulation. Coordination of follicular development may optimize ovarian response to short GnRH agonist and antagonist protocols, and constitutes an attractive approach to improving their outcome.
引用
收藏
页码:721 / 728
页数:8
相关论文
共 38 条
[1]  
Al-Inany H, 2001, COCHRANE DB SYST REV, V4
[2]  
Borm G, 2000, HUM REPROD, V15, P1490
[3]   Hormonal regulation of apoptosis in early antral follicles: Follicle-stimulating hormone as a major survival factor [J].
Chun, SY ;
Eisenhauer, KM ;
Minami, S ;
Billig, H ;
Perlas, E ;
Hsueh, AJW .
ENDOCRINOLOGY, 1996, 137 (04) :1447-1456
[4]   Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates [J].
Cramer, DW ;
Powers, DR ;
Oskowitz, SP ;
Liberman, RF ;
Hornstein, MD ;
McShane, PM ;
Barbieri, RL .
FERTILITY AND STERILITY, 1999, 72 (01) :83-89
[5]   Establishment of oocyte population in the fetal ovary: Primordial germ cell proliferation and oocyte programmed cell death [J].
De Felici, M ;
Klinger, FG ;
Farini, D ;
Scaldaferri, ML ;
Iona, S ;
Lobascio, M .
REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 10 (02) :182-191
[6]   A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix [J].
de Jong, D ;
Macklon, NS ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2000, 73 (05) :1051-1054
[7]   Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH) [J].
de Ziegler, D ;
Jääskeläinen, AS ;
BRioschi, PA ;
Fanchin, R ;
Bulletti, C .
HUMAN REPRODUCTION, 1998, 13 (03) :561-564
[8]   Selection of good embryos for transfer depends on embryo cohort size: implications for the 'mild ovarian stimulation' debate [J].
Devreker, F ;
Pogonici, E ;
De Maertelaer, V ;
Revelard, P ;
Van den Bergh, M ;
Englert, Y .
HUMAN REPRODUCTION, 1999, 14 (12) :3002-3008
[9]   SUPPRESSION OF THE ENDOGENOUS LUTEINIZING-HORMONE SURGE BY THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX DURING OVARIAN STIMULATION [J].
DIEDRICH, K ;
DIEDRICH, C ;
SANTOS, E ;
ZOLL, C ;
ALHASANI, S ;
REISSMANN, T ;
KREBS, D ;
KLINGMULLER, D .
HUMAN REPRODUCTION, 1994, 9 (05) :788-791
[10]   Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women [J].
Erb, K ;
Klipping, C ;
Duijkers, I ;
Pechstein, B ;
Schueler, A ;
Hermann, R .
FERTILITY AND STERILITY, 2001, 75 (02) :316-323